Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMALIZUMAB vs OMEPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OMALIZUMAB vs OMEPRAZOLE: Safety Overview

Metric OMALIZUMAB OMEPRAZOLE
Total FAERS Reports 63,846 87,111
Deaths Reported 1,713 8,515
Death Rate 2.7% 9.8%
Hospitalizations 11,178 19,847
Average Patient Age 51.0 yrs 58.7 yrs
% Female Patients 72.5% 58.9%
FDA Approval Date N/A Apr 17, 2009
Manufacturer CELLTRION, Inc. Cipla USA Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued